(Q46124016)

19 December 2017

title

Verapamil in treatment resistant depression: a role for the P-glycoprotein transporter? (English)

1 reference

19 December 2017

1 reference

1

1 reference

19 December 2017

Siobhain M O' Mahony

series ordinal

2

1 reference

19 December 2017

John F. Cryan

series ordinal

3

1 reference

19 December 2017

Timothy G. Dinan

series ordinal

4

1 reference

19 December 2017

publication date

1 April 2009

1 reference

19 December 2017

published in

Human Psychopharmacology

1 reference

19 December 2017

volume

24

1 reference

19 December 2017

issue

3

1 reference

19 December 2017

page(s)

217-223

1 reference

19 December 2017

Regional distribution of imipramine, desipramine and specific [3H]desipramine binding sites in the rat brain after acute and chronic treatment with imipramine.

cites work

1 reference

SSRIs versus tricyclic antidepressants in depressed inpatients: A meta-analysis of efficacy and tolerability

21 January 2018

1 reference

7 January 2021

In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation.

1 reference

7 January 2021

Calcium modulation of adherens and tight junction function: a potential mechanism for blood-brain barrier disruption after stroke

1 reference

7 January 2021

Assessment of the antidepressant-like effects of L-type voltage-dependent channel modulators.

1 reference

7 January 2021

Investigating the inflammatory phenotype of major depression: focus on cytokines and polyunsaturated fatty acids

1 reference

7 January 2021

Influence of P-glycoprotein inhibition on the distribution of the tricyclic antidepressant nortriptyline over the blood-brain barrier

1 reference

7 January 2021

Definition and epidemiology of treatment-resistant depression

1 reference

7 January 2021

Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoring

1 reference

7 January 2021

Tricyclic antidepressant pharmacology and therapeutic drug interactions updated

1 reference

7 January 2021

Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats

1 reference

7 January 2021

St Johns wort increases expression of P-glycoprotein: implications for drug interactions

1 reference

7 January 2021

Comparison of Verapamil, Diltiazem, and Labetalol on the Bioavailability and Metabolism of Imipramine

1 reference

7 January 2021

Regulation of multidrug resistance by pro-inflammatory cytokines.

1 reference

7 January 2021

Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 1).

1 reference

7 January 2021

Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 2).

1 reference

7 January 2021

Differential expression of multidrug resistance genes in naïve rat brain.

1 reference

7 January 2021

Regional expression of multidrug resistance genes in genetically epilepsy-prone rat brain after a single audiogenic seizure.

1 reference

7 January 2021

Blood-brain barrier active efflux transporters: ATP-binding cassette gene family

1 reference

7 January 2021

Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases

1 reference

7 January 2021

Protein components of the blood-brain barrier (BBB) in the mediobasal hypothalamus

1 reference

7 January 2021

The blood-brain barrier: bottleneck in brain drug development

1 reference

7 January 2021

Do antidepressants regulate how cortisol affects the brain?

1 reference

7 January 2021

P-Glycoprotein, a gatekeeper in the blood-brain barrier

1 reference

7 January 2021

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.

1 reference

7 January 2021

Expression of the multidrug transporter P-glycoprotein in brain capillary endothelial cells and brain parenchyma of amygdala-kindled rats.

1 reference

7 January 2021

Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis

1 reference

7 January 2021

Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy

1 reference

7 January 2021

A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of 'vascular depression'.

1 reference

7 January 2021

A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of "vascular depression".

1 reference

7 January 2021

Overcoming Multidrug Resistance in Cancer: An Update on the Clinical Strategy of Inhibiting P-Glycoprotein

1 reference

7 January 2021

Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption

1 reference

7 January 2021

Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression

1 reference

7 January 2021

Increased expression of the multidrug transporter P-glycoprotein in limbic brain regions after amygdala-kindled seizures in rats

1 reference

7 January 2021

The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein

1 reference

7 January 2021

Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood-brain barrier of Abcb1a gene knockout mice

1 reference

7 January 2021

Therapeutic drugs that behave as mechanism-based inhibitors of cytochrome P450 3A4

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.1008

1 reference

19 December 2017

PubMed ID

19212940

1 reference

19 December 2017